Showing results (891-900 of 5,837) with videos related to

Sort By:
Pageof 584
Drug Design, Development and Therapy|February 25, 2015
Clinical utility of eslicarbazepine: current evidenceGaetano Zaccara, Fabio Giovannelli, Massimo Cincotta, et al.
Drug Design, Development and Therapy|February 25, 2015
Efficacy and safety of a herbal mixture (Viron® tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept studyHisham Shawkat, Mostafa Yakoot, Tarek Shawkat, et al.
Drug Design, Development and Therapy|February 25, 2015
In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic applicationRon Clijsen, Jean Pierre Baeyens, André Odilon Barel, et al.
Drug Design, Development and Therapy|June 20, 2014
Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironmentKosuke Narise, Kensuke Okuda, Yukihiro Enomoto, et al.
Drug Design, Development and Therapy|February 12, 2015
Nanoparticle formulation by Büchi B-90 Nano Spray Dryer for oral mucoadhesionSree N Harsha, Bander E Aldhubiab, Anroop B Nair, et al.
Drug Design, Development and Therapy|February 12, 2015
Antiaging therapy: a prospective hypothesisMohammad Rashid Shahidi Bonjar, Leyla Shahidi Bonjar
Drug Design, Development and Therapy|May 23, 2023
Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi'an, ChinaHuan Xia, Juan Jin, Huanhuan Ba, et al.
Drug Design, Development and Therapy|July 17, 2020
Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel InhibitionJan Hansen, Jacob Johnsen, Jan Møller Nielsen, et al.
Drug Design, Development and Therapy|April 8, 2015
Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental studyŞehmus Pala, Remzi Atilgan, Zehra Sema Ozkan, et al.
Drug Design, Development and Therapy|April 8, 2015
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinomaChongyi Li, Yanli Xiong, Xueqin Yang, et al.
Pageof 584